Vγ9Vδ2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapy
- 8 August 2005
- journal article
- review article
- Published by Elsevier in Immunology Letters
- Vol. 100 (1) , 14-20
- https://doi.org/10.1016/j.imlet.2005.06.025
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: exploring the immunological mechanismsEuropean Journal of Immunology, 2004
- GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorderJournal of Clinical Investigation, 2001
- A chemical basis for recognition of nonpeptide antigens by human γδ T cells*The FASEB Journal, 2000
- Human γδ T Cells Recognize Alkylamines Derived from Microbes, Edible Plants, and TeaImmunity, 1999
- Viral Clearance Without Destruction of Infected Cells During Acute HBV InfectionScience, 1999
- The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entryNature, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- Human Vγ9‐Vδ2 cells are stimulated in a crossreactive fashion by a variety of phosphorylated metabolitesEuropean Journal of Immunology, 1995
- Stimulation of Human γδ T Cells by Nonpeptidic Mycobacterial LigandsScience, 1994
- Dengue virus infection of human skin fibroblasts in vitro production of IFN-?, IL-6 and GM-CSFArchiv für die gesamte Virusforschung, 1992